Mapping and Understanding Production of Natural Products in Fungi
绘制和了解真菌天然产物的生产
基本信息
- 批准号:10677824
- 负责人:
- 金额:$ 52.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-04-01 至 2027-05-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAccountingActinobacteria classAddressAgrochemicalsAntibioticsAntifungal AgentsAntineoplastic AgentsAntiparasitic AgentsAscomycotaAspergillus nidulansBacteriaBioinformaticsBiologicalCaspofunginCellsChemicalsChromosomesClinicalCloningCollaborationsCollectionCyclosporinsDataData SetEuchromatinFundingFungal GenomeFutureGene ClusterGenerationsGenesGeneticGenomeGenomic approachGenomicsGenotypeGoalsHistonesHot SpotImmuneImprove AccessInflammatory ResponseLinkLovastatinMapsMass Spectrum AnalysisMedicineMetabolismMethodologyMethodsModelingMolecular BiologyNatural ProductsOutputPathway interactionsPenicillinsPhenotypeProductionProteinsPublic HealthReaderRecording of previous eventsReporterResearchSecureSoilSourceSterigmatocystinStructureSurveysTechnologyTertiary Protein StructureTestingTherapeuticTimeViralWorkZebrafishbioactive natural productseconomic valuefungusgenome sequencinggenomic locusimmunoregulationimprovedinsightmembermetabolomicsmigrationneutrophilnew technologynoveloverexpressionpermissivenessresponsescreeningscreening programsecondary metabolitesuccesstool
项目摘要
Project Summary/Abstract
The goal of this project is to improve a genome-driven, correlation-based platform to unearth and produce
new bioactive compounds from fungi. This platform and research will deliver access to a large repertoire of fungal
natural products (NPs), which historically have been a great source of new medicines and useful compounds.
Typical estimates have NPs and their derivatives accounting for ca. 75% of currently used antibiotics and nearly
60% of anti-cancer drugs along with numerous antiviral, antiparasitic, antifungal, and immunosuppressive
medicines. Despite their historical successes, traditional screening programs have been severely curtailed due
to declining numbers of promising new candidates and lack of ready access to new compounds. At the same
time, analysis of over one thousand fungal genomes suggests that tens of thousands of high-value NPs have
yet to be identified and screened. Thus, new technologies are needed and here we describe an integrated plan
to systematically tap into this vast potential of fungal metabolites through genomics, metabolomics, bioactivity
screening and molecular biology. In the previous funding period, we developed an untargeted approach called
`metabologenomics' that correlates genomic content with metabolite output to uncover hundreds of new NPs
and their gene clusters from soil actinobacteria. In this competing renewal, we now propose to extend the method
to 300 fungi while integrating bioactivity screening in Aim 1. Activities described in this proposal will reduce
technical barriers by establishing new workflows, improving experimental methodology, and refining scoring
metrics to create a discovery platform with the ability to help unlock the medicinal potential of NPs in the fungal
kingdom. In Aim 2, we focus on the targeted capture and expression of BGCs in specific euchromatic loci in a
widely used host for NP heterologous expression, Aspergillus nidulans. The two Aims of the project describe the
generation of genomic, metabolomics, bioactivity, and expression data. We further propose to make data- and
milestone-driven progress on the combination of these complementary data types to systematically examine a
set of 300 fungal strains. With a proven track record of deep collaboration among the team members involved,
we will deliver a robust implementation of the proposed activities to provide a well-defined path to discovery of
bioactive NP/BGC pairs, and study the production of new molecules from diverse fungi.
项目总结/摘要
该项目的目标是改进一个基因组驱动的、基于相关性的平台,
真菌中的新生物活性化合物。这个平台和研究将提供访问大量的真菌
天然产物(NPs),历史上一直是新药和有用化合物的重要来源。
典型的估计有NP及其衍生物约占。目前使用的抗生素中有75%,
60%的抗癌药物沿着众多的抗病毒、抗寄生虫、抗真菌和免疫抑制药物
药尽管他们的历史成功,传统的筛选程序已严重削减,由于
有希望的新候选药物数量减少,以及缺乏现成的新化合物。在同一
同时,对一千多个真菌基因组的分析表明,数万个高价值的NP具有
还有待鉴定和筛选因此,需要新的技术,在这里,我们描述了一个综合计划
通过基因组学,代谢组学,生物活性,
筛选和分子生物学。在上一个资助期,我们开发了一种非目标性方法,
“代谢基因组学”,将基因组含量与代谢产物输出相关联,以发现数百种新的NP
和它们的基因簇。在这个竞争性的更新中,我们现在建议扩展该方法
对300株真菌进行了生物活性筛选。本提案所述活动将减少
通过建立新的工作流程、改进实验方法和改进评分来克服技术障碍
这些指标创建了一个发现平台,能够帮助释放真菌中NP的药用潜力。
王国在目标2中,我们关注BGC在特定常染色质基因座中的靶向捕获和表达,
广泛用于NP异源表达的宿主是构巢曲霉。该项目的两个目标描述了
基因组学、代谢组学、生物活性和表达数据的生成。我们进一步提出,使数据-和
这些互补数据类型组合的里程碑驱动进展,以系统地检查
300种真菌菌株凭借团队成员之间深入合作的良好记录,
我们将提供一个强大的实施建议的活动,以提供一个明确的路径,发现
生物活性NP/BGC配对,并研究从不同真菌中产生新分子。
项目成果
期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Discovery of the Biosynthetic Machinery for Stravidins, Biotin Antimetabolites.
斯特拉维素、生物素抗代谢物生物合成机制的发现。
- DOI:10.1021/acschembio.9b00890
- 发表时间:2020
- 期刊:
- 影响因子:4
- 作者:Montaser,Rana;Kelleher,NeilL
- 通讯作者:Kelleher,NeilL
Selective Targeting by a Mechanism-Based Inactivator against Pyridoxal 5'-Phosphate-Dependent Enzymes: Mechanisms of Inactivation and Alternative Turnover.
- DOI:10.1021/acs.biochem.7b00499
- 发表时间:2017-09-19
- 期刊:
- 影响因子:2.9
- 作者:Mascarenhas R;Le HV;Clevenger KD;Lehrer HJ;Ringe D;Kelleher NL;Silverman RB;Liu D
- 通讯作者:Liu D
Discovery of the Tyrobetaine Natural Products and Their Biosynthetic Gene Cluster via Metabologenomics.
- DOI:10.1021/acschembio.7b01089
- 发表时间:2018-04-20
- 期刊:
- 影响因子:4
- 作者:Parkinson EI;Tryon JH;Goering AW;Ju KS;McClure RA;Kemball JD;Zhukovsky S;Labeda DP;Thomson RJ;Kelleher NL;Metcalf WW
- 通讯作者:Metcalf WW
Genome Mining and Metabolomics Uncover a Rare d-Capreomycidine Containing Natural Product and Its Biosynthetic Gene Cluster.
- DOI:10.1021/acschembio.0c00663
- 发表时间:2020-11-20
- 期刊:
- 影响因子:4
- 作者:Tryon JH;Rote JC;Chen L;Robey MT;Vega MM;Phua WC;Metcalf WW;Ju KS;Kelleher NL;Thomson RJ
- 通讯作者:Thomson RJ
Streptomyces buecherae sp. nov., an actinomycete isolated from multiple bat species.
- DOI:10.1007/s10482-020-01493-4
- 发表时间:2020-12
- 期刊:
- 影响因子:0
- 作者:Hamm PS;Dunlap CA;Mullowney MW;Caimi NA;Kelleher NL;Thomson RJ;Porras-Alfaro A;Northup DE
- 通讯作者:Northup DE
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NEIL L KELLEHER其他文献
NEIL L KELLEHER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NEIL L KELLEHER', 18)}}的其他基金
Chemistry of Life Processes Predoctoral Training Program
生命过程化学博士前培训项目
- 批准号:
10628231 - 财政年份:2023
- 资助金额:
$ 52.79万 - 项目类别:
Multi-Omics And Synbio Enabled Discovery Of Antifungal Fernene Triterpenes
多组学和 Synbio 发现抗真菌蕨烯三萜
- 批准号:
10601431 - 财政年份:2023
- 资助金额:
$ 52.79万 - 项目类别:
Defining native proteoform landscape for amyloid-beta in Alzheimers disease
定义阿尔茨海默病中β淀粉样蛋白的天然蛋白质形态
- 批准号:
9803611 - 财政年份:2019
- 资助金额:
$ 52.79万 - 项目类别:
Renewable and Specific Affinity Reagents for Mapping Proteoforms in Human Tissues
用于绘制人体组织中蛋白质组图谱的可再生特异性亲和试剂
- 批准号:
9894469 - 财政年份:2019
- 资助金额:
$ 52.79万 - 项目类别:
Renewable and Specific Affinity Reagents for Mapping Proteoforms in Human Tissues
用于绘制人体组织中蛋白质组图谱的可再生特异性亲和试剂
- 批准号:
10249071 - 财政年份:2019
- 资助金额:
$ 52.79万 - 项目类别:
National Resource for Translational and Developmental Proteomics
国家转化和发育蛋白质组学资源
- 批准号:
9456539 - 财政年份:2017
- 资助金额:
$ 52.79万 - 项目类别:
Mass Spectrometric Studies of Thiotemplate Biosynthesis
硫模板生物合成的质谱研究
- 批准号:
9240599 - 财政年份:2016
- 资助金额:
$ 52.79万 - 项目类别:
Mapping and Understanding Production of Natural Products in Fungi
绘制和了解真菌天然产物的生产
- 批准号:
10522724 - 财政年份:2016
- 资助金额:
$ 52.79万 - 项目类别:
Mass Spectrometric Studies of Thiotemplate Biosynthesis
硫模板生物合成的质谱研究
- 批准号:
9905491 - 财政年份:2016
- 资助金额:
$ 52.79万 - 项目类别:
National Resource for Translational and Developmental Proteomics
国家转化和发育蛋白质组学资源
- 批准号:
9283567 - 财政年份:2015
- 资助金额:
$ 52.79万 - 项目类别:
相似海外基金
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 52.79万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Mighty Accounting - Accountancy Automation for 1-person limited companies.
Mighty Accounting - 1 人有限公司的会计自动化。
- 批准号:
10100360 - 财政年份:2024
- 资助金额:
$ 52.79万 - 项目类别:
Collaborative R&D
Accounting for the Fall of Silver? Western exchange banking practice, 1870-1910
白银下跌的原因是什么?
- 批准号:
24K04974 - 财政年份:2024
- 资助金额:
$ 52.79万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
CPS: Medium: Making Every Drop Count: Accounting for Spatiotemporal Variability of Water Needs for Proactive Scheduling of Variable Rate Irrigation Systems
CPS:中:让每一滴水都发挥作用:考虑用水需求的时空变化,主动调度可变速率灌溉系统
- 批准号:
2312319 - 财政年份:2023
- 资助金额:
$ 52.79万 - 项目类别:
Standard Grant
A New Direction in Accounting Education for IT Human Resources
IT人力资源会计教育的新方向
- 批准号:
23K01686 - 财政年份:2023
- 资助金额:
$ 52.79万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
An empirical and theoretical study of the double-accounting system in 19th-century American and British public utility companies
19世纪美国和英国公用事业公司双重会计制度的实证和理论研究
- 批准号:
23K01692 - 财政年份:2023
- 资助金额:
$ 52.79万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
An Empirical Analysis of the Value Effect: An Accounting Viewpoint
价值效应的实证分析:会计观点
- 批准号:
23K01695 - 财政年份:2023
- 资助金额:
$ 52.79万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accounting model for improving performance on the health and productivity management
提高健康和生产力管理绩效的会计模型
- 批准号:
23K01713 - 财政年份:2023
- 资助金额:
$ 52.79万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
New Role of Not-for-Profit Entities and Their Accounting Standards to Be Unified
非营利实体的新角色及其会计准则将统一
- 批准号:
23K01715 - 财政年份:2023
- 资助金额:
$ 52.79万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Improving Age- and Cause-Specific Under-Five Mortality Rates (ACSU5MR) by Systematically Accounting Measurement Errors to Inform Child Survival Decision Making in Low Income Countries
通过系统地核算测量误差来改善特定年龄和特定原因的五岁以下死亡率 (ACSU5MR),为低收入国家的儿童生存决策提供信息
- 批准号:
10585388 - 财政年份:2023
- 资助金额:
$ 52.79万 - 项目类别: